
Multiplex Assays Market by Product & Service (Consumables, Instruments, Software & Services), Type (Cell-Based Multiplex Assays, Nucleic Acid Multiplex Assays, Protein Multiplex Assays), Technology, Application, End User - Global Forecast 2024-2030
Description
Multiplex Assays Market by Product & Service (Consumables, Instruments, Software & Services), Type (Cell-Based Multiplex Assays, Nucleic Acid Multiplex Assays, Protein Multiplex Assays), Technology, Application, End User - Global Forecast 2024-2030
The Multiplex Assays Market size was estimated at USD 3.89 billion in 2023 and expected to reach USD 4.21 billion in 2024, at a CAGR 8.50% to reach USD 6.88 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Multiplex Assays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Multiplex Assays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Multiplex Assays Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Antigenix America, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cayman Chemical Company, Charles River Laboratories, Enfer Group, Enzo Life Sciences, Inc., Eve Technologies Corp., Flagship Biosciences Inc., Future Diagnostics Solutions B.V., Gnome Diagnostics and Gnome Sciences, Illumina, Inc., Merck KGaA, MESO SCALE DIAGNOSTICS, LLC, Novatein Biosciences Inc., PerkinElmer, Inc., Protavio Ltd., Siemens Healthineers AG, Solis BioDyne OÜ, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Multiplex Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product & Service
Consumables
Instruments
Software & Services
Type
Cell-Based Multiplex Assays
Nucleic Acid Multiplex Assays
Bead-Based Nucleic Acid Assays
Planar Nucleic Acid Assays
Protein Multiplex Assays
Bead-Based Protein Assays
Planar Protein Assays
Technology
Flow Cytometry
Fluorescence Detection
Luminescence
Multiplex Real-Time Flow Cytometry
Multiplex Real-Time PCR
Application
Clinical Diagnostics
Autoimmune Diseases
Cancer
Cardiovascular Diseases
Infectious Diseases
Metabolism & Endocrinology Disorders
Nervous System Disorders
Research & Development
Biomarker Discovery & Validation
Drug Discovery & Development
End User
Hospitals & Research Institutes
Pharmaceutical & Biotechnology Companies
Reference Laboratories
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Multiplex Assays Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Multiplex Assays Market?
3. What are the technology trends and regulatory frameworks in the Multiplex Assays Market?
4. What is the market share of the leading vendors in the Multiplex Assays Market?
5. Which modes and strategic moves are suitable for entering the Multiplex Assays Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
196 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Multiplex Assays Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising chronic and infectious disease and rapid shift towards early diagnosis
- 5.1.1.2. Surge in usage of personalized-precision medications
- 5.1.1.3. Growing application of multiple assays in drug development
- 5.1.2. Restraints
- 5.1.2.1. Associated shear complexity of multiplex assays and high cost of instruments
- 5.1.3. Opportunities
- 5.1.3.1. Emerging technology of multiplexing in clinical diagnostics
- 5.1.3.2. Potential adoption of automated instruments and equipment in clinical practice
- 5.1.4. Challenges
- 5.1.4.1. Shortage of skilled and experienced healthcare professionals
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Multiplex Assays Market, by Product & Service
- 6.1. Introduction
- 6.2. Consumables
- 6.3. Instruments
- 6.4. Software & Services
- 7. Multiplex Assays Market, by Type
- 7.1. Introduction
- 7.2. Cell-Based Multiplex Assays
- 7.3. Nucleic Acid Multiplex Assays
- 7.4.1. Bead-Based Nucleic Acid Assays
- 7.4.2. Planar Nucleic Acid Assays
- 7.4. Protein Multiplex Assays
- 7.5.1. Bead-Based Protein Assays
- 7.5.2. Planar Protein Assays
- 8. Multiplex Assays Market, by Technology
- 8.1. Introduction
- 8.2. Flow Cytometry
- 8.3. Fluorescence Detection
- 8.4. Luminescence
- 8.5. Multiplex Real-Time Flow Cytometry
- 8.6. Multiplex Real-Time PCR
- 9. Multiplex Assays Market, by Application
- 9.1. Introduction
- 9.2. Clinical Diagnostics
- 9.3.1. Autoimmune Diseases
- 9.3.2. Cancer
- 9.3.3. Cardiovascular Diseases
- 9.3.4. Infectious Diseases
- 9.3.5. Metabolism & Endocrinology Disorders
- 9.3.6. Nervous System Disorders
- 9.3. Research & Development
- 9.4.1. Biomarker Discovery & Validation
- 9.4.2. Drug Discovery & Development
- 10. Multiplex Assays Market, by End User
- 10.1. Introduction
- 10.2. Hospitals & Research Institutes
- 10.3. Pharmaceutical & Biotechnology Companies
- 10.4. Reference Laboratories
- 11. Americas Multiplex Assays Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Multiplex Assays Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Multiplex Assays Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. FPNV Positioning Matrix
- 14.2. Market Share Analysis, By Key Player
- 14.3. Competitive Scenario Analysis, By Key Player
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.1.1. Abbott Laboratories
- 15.1.2. Abcam PLC
- 15.1.3. Agilent Technologies, Inc.
- 15.1.4. Antigenix America, Inc.
- 15.1.5. Becton, Dickinson and Company
- 15.1.6. Bio-Rad Laboratories, Inc.
- 15.1.7. Bio-Techne Corporation
- 15.1.8. Cayman Chemical Company
- 15.1.9. Charles River Laboratories
- 15.1.10. Enfer Group
- 15.1.11. Enzo Life Sciences, Inc.
- 15.1.12. Eve Technologies Corp.
- 15.1.13. Flagship Biosciences Inc.
- 15.1.14. Future Diagnostics Solutions B.V.
- 15.1.15. Gnome Diagnostics and Gnome Sciences
- 15.1.16. Illumina, Inc.
- 15.1.17. Merck KGaA
- 15.1.18. MESO SCALE DIAGNOSTICS, LLC
- 15.1.19. Novatein Biosciences Inc.
- 15.1.20. PerkinElmer, Inc.
- 15.1.21. Protavio Ltd.
- 15.1.22. Siemens Healthineers AG
- 15.1.23. Solis BioDyne OÜ
- 15.1.24. Thermo Fisher Scientific Inc.
- 15.2. Key Product Portfolio
- 16. Appendix
- 16.1. Discussion Guide
- 16.2. License & Pricing
- FIGURE 1. MULTIPLEX ASSAYS MARKET RESEARCH PROCESS
- FIGURE 2. MULTIPLEX ASSAYS MARKET SIZE, 2023 VS 2030
- FIGURE 3. MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. MULTIPLEX ASSAYS MARKET DYNAMICS
- FIGURE 7. MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
- FIGURE 8. MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 10. MULTIPLEX ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 12. MULTIPLEX ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 16. MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 20. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 25. MULTIPLEX ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 26. MULTIPLEX ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.